Peggy Oconnor
Family · Rapid City, SDNPI 1710235213
Payments from drug & device makers
Across 51 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$266
- Sunovion Pharmaceuticals Inc.$131
- Teva Pharmaceuticals USA, Inc.$100
- Neurocrine Biosciences, Inc.$74
- Johnson & Johnson$71
- Alkermes, Inc.$70
- plus $161 from 6 others
What the payments were for
- Food & beverage$874100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $266 |
| Sunovion Pharmaceuticals Inc. | 7 | $131 |
| Teva Pharmaceuticals USA, Inc. | 6 | $100 |
| Neurocrine Biosciences, Inc. | 4 | $74 |
| Johnson & Johnson | 5 | $71 |
| Alkermes, Inc. | 4 | $70 |
| Supernus Pharmaceuticals, Inc. | 3 | $41 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Eisai Inc. | 2 | $28 |
| Merck | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
How this compares
$874 in reported general payments places this provider in the 75th percentile of 588 family providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $25,331 |
| JardianceEmpagliflozin | 15 | $22,203 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $2,665 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $999 |
| Metformin Hcl | 33 | $422 |
| Tamsulosin Hcl | 12 | $422 |
| Atorvastatin Calcium | 23 | $263 |
| Metoprolol Succinate | 11 | $241 |
| Lisinopril | 32 | $226 |
| Losartan Potassium | 29 | $218 |
| Levothyroxine Sodium | 17 | $195 |
| Azithromycin | 14 | $172 |
| Pantoprazole Sodium | 12 | $153 |
| Aripiprazole | 11 | $129 |
| Oxycodone Hcl | 12 | $124 |
Paid to pharmacies, not to this prescriber.
Other family in Rapid City
- Claudia HouglandRapid City$9K
- Melissa OwensRapid City$6K
- Kristen DirksRapid City$5K
- Janessa HuntRapid City$5K
- Rebecca ChristensenRapid City$5K
- Jamie SlettedahlRapid City$4K
- Kristy SchumacherRapid City$4K
- Vanessa PribilRapid City$3K
- Rachel WaddellRapid City$3K
- Kelsey JohnsonRapid City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.